Order without science

On June 28, 1993, the Supreme Court of the us passed a verdict that tilted the scales of justice in favour of polluters by undermining the role …

Drug pricing body puts cap on trade margin for 42 anti-cancer drugs

Experts say move will not benefit patients as drug prices are already too high and the cap only negligible

Reusing wastewater

A new technology to remove chloroform from the wastewater of drug plants

A fine balance

The bill keeps national interests intact and remains TRIPS compliant

Broad spectrum drugs rule India

Seminars promote patents

Cipla puts US law school on notice     

When supervisors cheat

Book>> Experiment eleven, dark secrets behind the discovery of a wonder drug • by Peter Pringle • Bloomsbury • Rs 1,700

Higher royalty payments offered as bait to MNCs

In an effort to improve the quality of technology coming into the country, the Indian government has decided to remove the low ceiling on royalty …

Virtual reality

A new computing laboratory can project larger than real life images of human body's smallest part

Suspect claims in Teva’s suit against Cipla

The US Federal Trade Commission has warned the Israeli drug firm its patents are wrongful as it sues Cipla aggressively

Centre fails to weed out substandard drugs, reign in prices: Parl panel

It recommends that the government adopt cost of production-based pricing system

Malaria-free India: A vision may be more achievable now

The US’ FDA has approved a drug that can flush out a recurring parasite that causes 34 per cent malaria cases in India

Drug companies are buying doctors – for as little as a $16 meal

An important new study in the United States has found doctors who receive just one cheap meal from a drug company tend to prescribe a lot more of …

Three-in-one offer

Human testing debate resurfaces

Pharmaceutical company seeks to use human data to promote pesticides

Pill trouble

Dabur given go-ahead to market birth defect-causing drug

Prickly issue

Will the inclusion of Hepatitis B vaccination in the Universal Immunisation Programme help?

Bone damage

Effluents threaten Nilgiri

Protests against Abbott laboratory in Bangkok

Zyprexa, of pharma major Elli Lilly, promoted for off-label uses

Scan combo drugs

Health schemes caught between government & World Bank

Double standards

Donate patents

South Asia